Skip to main content

Advertisement

SpringerLink
Log in

Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Adenocarcinomas of the uterine cervix show a wide range of morphological features, and can be confused with endometrial adenocarcinoma in biopsy or curetting specimens. The objective of this study was to use tissue microarray technology to evaluate the immunoprofile of a large set of uterine adenocarcinomas with an extended panel of antibodies, comparing the profile of primary cervical and endometrial adenocarcinomas. A tissue microarray was constructed using paraffin-embedded, formalin-fixed tissues from 141 hysterectomy specimens. Duplicate 0.6-mm cores were obtained from 57 cervical adenocarcinomas (16 in situ and 41 invasive) and 84 endometrial adenocarcinomas. Tissue array sections were immunostained with 21 commercially available antibodies [B72.3, CD 99, carcinoembryonic antigen (CEA), c-kit, pancytokeratin, CK 5/6, CK 7, CK8/18, CK19, CK 20, CK 22, EMA, estrogen receptor (ER), KP-1, melan-A, p53, PLAP, S-100, synaptophysin, TTF-1, and vimentin] utilizing the avidin-biotin (ABC) technique. Hierarchical clustering analysis of the tumors was done based on the immunostaining results. Only ER (P<0.001), CEA (P=0.04), vimentin (P<0.001), and CK 8/18 (P=0.002) showed a significantly different frequency of positivity in endometrial relative to cervical adenocarcinomas. ER, vimentin, and CK 8/18 were more likely to be expressed in endometrial adenocarcinomas, while cervical adenocarcinomas more frequently expressed CEA. We were able to identify immunoprofiles that were highly specific for endocervical adenocarcinoma (ER−, vimentin−, CK 8/18−, CEA+) or endometrial adenocarcinoma (ER+, vimentin+, CK 8/18+, CEA−), but most tumors showed an intermediate, non-specific immunophenotype. Hierarchical clustering analysis was useful in the interpretation of these intermediate immunophenotypes. Papillary serous adenocarcinoma of the endometrium was less likely to express vimentin (P=0.002) than endometrioid carcinoma of the endometrium.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Staudt LM, et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503–511

    PubMed  Google Scholar 

  2. Azumi N, Battifora H (1987) The distribution of vimentin and keratin in epithelial and non-epithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am J Clin Pathol 88:286–296

    CAS  PubMed  Google Scholar 

  3. Camp RL, Charette LA, Rimm DL (2000) Validation of tissue microarray technology in breast carcinoma. Lab Invest 80:1943–1949

    CAS  PubMed  Google Scholar 

  4. Castrillon DH, Lee KR, Nucci MR (2002) Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Int J Gynecol Pathol 21:4–10

    PubMed  Google Scholar 

  5. Cohen C, Shulman G, Budgeon LR (1982) Endocervical and endometrial adenocarcinoma: an immunoperoxidase and histochemical study. Am J Surg Pathol 6:151–157

    CAS  PubMed  Google Scholar 

  6. Dabbs DJ, Geisinger KR, Norris HT (1986) Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 10:568–576

    CAS  PubMed  Google Scholar 

  7. Dabbs DJ, Sturtz K, Zaino RJ (1996) The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum Pathol 27:172–177

    CAS  PubMed  Google Scholar 

  8. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:14863–14868

    CAS  PubMed  Google Scholar 

  9. Fujiwara H, Tortolero-Luna G, Mitchell MF, Koulos JP, Wright TC Jr. (1997) Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors. Cancer 79:505–512

    Article  CAS  PubMed  Google Scholar 

  10. Ghandour FA, Attanoos R, Nahar K, Gee JW, Bigrigg A, Ismail SM (1994) Immunocytochemical localization of oestrogen and progesterone receptors in primary adenocarcinoma of the cervix. Histopathology 24:49–55

    CAS  PubMed  Google Scholar 

  11. Golub T R, Slonim D K, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, Coller H, Loh ML, Downing JR, Caligiuri MA, Bloomfield CD, Lander ES (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286:531–537

    Article  PubMed  Google Scholar 

  12. Halperin R, Zehavi S, Habler L, Hadas E, Bukowsky I, Schneider D (2001) Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of the endometrium. Eur J Gynaecol Oncol 22:122–126

    CAS  PubMed  Google Scholar 

  13. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP (1998) Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4:844–847

    CAS  PubMed  Google Scholar 

  14. Liu CL, Prapong W, Natkuman Y, Alizadeh A, Montgomery K, Gilks CB, van de Rijn M (2002) Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 161:1557–1565

    CAS  PubMed  Google Scholar 

  15. Maes G, Fleuren G, Bara J, Nap M (1988) The distribution of mucins, carcinoembryonic antigen, and mucus-associated antigens in endocervical and endometrial adenocarcinomas. Int J Gynecol Pathol 7:112–122

    CAS  PubMed  Google Scholar 

  16. Masood S, Rhatigan RM, Wilkinson EW, Barwick KW, Wilson WJ (1993) Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study. Cancer 72:511–518

    CAS  PubMed  Google Scholar 

  17. McCluggage WG, Sumathi VP, McBride HA, Patterson A (2002) A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 21:11–15

    PubMed  Google Scholar 

  18. Nocito A, Bubendorf NA, Maria Tinner E, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T, Schoenberger AJ, Flury R, Jager P, Luc Fehr J, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G (2001) Microarrays of bladder cancer tissue are highly representative of proliferative index and histological grade. J Pathol 194:349–357

    CAS  PubMed  Google Scholar 

  19. Parker R, Cupples J, Lesack D, Grant D, Huntsman D, Gilks CB (2002) Assessment of inter observer variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray. Am J Clin Pathol 117:723–728

    PubMed  Google Scholar 

  20. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406:747–752

    CAS  PubMed  Google Scholar 

  21. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van De Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lonning P, Borreson-Dale AL (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 98:10869–10874

    Article  CAS  PubMed  Google Scholar 

  22. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, Mross F, Dietrich H, Moch H, Mihatsch M, Kallioniemi OP, Sauter G (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159:2249–2256

    PubMed  Google Scholar 

  23. Zaino RJ (2002) The fruits of our labors: Distinguishing endometrial from endocervical adenocarcinoma. Int J Gynecol Pathol 21:1–3

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Genetic Pathology Evaluation Center, Department of Pathology, 1st floor JPPN, Vancouver General Hospital, 855 W. 12th Avenue, Vancouver, BC V5Z 1M9, Canada

    A. Alkushi, J. Irving, F. Hsu, B. Dupuis & C. B. Gilks

  2. Department of Biochemistry, Stanford University, Stanford , CA

    C. L. Liu

  3. Department of Pathology, Stanford University, Stanford , CA

    M. van de Rijn

Authors
  1. A. Alkushi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Irving
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Dupuis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. L. Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. van de Rijn
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. B. Gilks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. B. Gilks.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alkushi, A., Irving, J., Hsu, F. et al. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch 442, 271–277 (2003). https://doi.org/10.1007/s00428-002-0752-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-002-0752-4

Keywords

Search

Navigation